The antiinflammatory effect of minocycline at the early stage of pericyte-depletion retinopathy was corroborated by the downregulation of CCL2, iNOS, TSPO, and LGALS3 in minocycline-treated APB5 retinas at P10. This evidence concerns the gene CCL2 and retinal disorder.